Ticker

TGTX

TG Therapeutics, Inc.

3 catalysts on file

TGTX

TG Therapeutics, Inc.

Phase 3 Confirmed

BRIUMVI (ublituximab-xiiy)

relapsing forms of multiple sclerosis (RMS)

86d ago May 27, 2026

SEC 8-K verified 2mo ago

Countdown card →

TGTX

TG Therapeutics, Inc.

Phase 3 Confirmed

BRIUMVI

relapsing forms of multiple sclerosis (RMS)

86d ago May 27, 2026

SEC 8-K verified 2mo ago

Countdown card →

TGTX

TG Therapeutics, Inc.

Catalyst AI-extracted

BRIUMVI

relapsing forms of multiple sclerosis (RMS)

T-minus 132 days ~ Dec 31, 2026

SEC 8-K verified 2mo ago

Countdown card →